These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
554 related articles for article (PubMed ID: 14506169)
1. Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds. Ouatas T; Halverson D; Steeg PS Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3763-72. PubMed ID: 14506169 [TBL] [Abstract][Full Text] [Related]
2. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer. Palmieri D; Halverson DO; Ouatas T; Horak CE; Salerno M; Johnson J; Figg WD; Hollingshead M; Hursting S; Berrigan D; Steinberg SM; Merino MJ; Steeg PS J Natl Cancer Inst; 2005 May; 97(9):632-42. PubMed ID: 15870434 [TBL] [Abstract][Full Text] [Related]
3. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Leone A; Flatow U; VanHoutte K; Steeg PS Oncogene; 1993 Sep; 8(9):2325-33. PubMed ID: 8395676 [TBL] [Abstract][Full Text] [Related]
4. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2. Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192 [TBL] [Abstract][Full Text] [Related]
5. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition. Hartsough MT; Clare SE; Mair M; Elkahloun AG; Sgroi D; Osborne CK; Clark G; Steeg PS Cancer Res; 2001 Mar; 61(5):2320-7. PubMed ID: 11280805 [TBL] [Abstract][Full Text] [Related]
6. Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer. Hua K; Feng W; Cao Q; Zhou X; Lu X; Feng Y Int J Oncol; 2008 Nov; 33(5):959-67. PubMed ID: 18949358 [TBL] [Abstract][Full Text] [Related]
7. [Molecular mechanism of reversing metastatic phenotype in human high-metastatic large cell lung cancer cell line L9981 by nm23-H1]. Che GW; Zhou QH; Zhu W; Wang YP; Qin Y; Liu LX; Chen XH; Sun YL; Sun ZF Ai Zheng; 2005 Mar; 24(3):278-84. PubMed ID: 15757527 [TBL] [Abstract][Full Text] [Related]
8. P53 is a regulator of the metastasis suppressor gene Nm23-H1. Chen SL; Wu YS; Shieh HY; Yen CC; Shen JJ; Lin KH Mol Carcinog; 2003 Apr; 36(4):204-14. PubMed ID: 12669312 [TBL] [Abstract][Full Text] [Related]
9. [Influence of estrogen and progestin on nm23-H1 expression in epithelial ovarian cancer cell lines via activation of phosphorylation signaling]. Hua KQ; Yao LQ; Cao Q; Huang Y; Zhao YQ; Feng YJ Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):756-61. PubMed ID: 17327034 [TBL] [Abstract][Full Text] [Related]
11. ErbB2 and the antimetastatic nm23/NDP kinase in regulating serum induced breast cancer invasion. Tommasi S; Fedele V; Crapolicchio A; Bellizzi A; Paradiso A; Reshkin SJ Int J Mol Med; 2003 Jul; 12(1):131-4. PubMed ID: 12792823 [TBL] [Abstract][Full Text] [Related]
12. Transfection of the nm23-H1 gene into human hepatocarcinoma cell line inhibits the expression of sialyl Lewis X, alpha1,3 fucosyltransferase VII, and metastatic potential. Liu F; Zhang Y; Zhang XY; Chen HL J Cancer Res Clin Oncol; 2002 Apr; 128(4):189-96. PubMed ID: 11935309 [TBL] [Abstract][Full Text] [Related]
14. Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981. Che G; Chen J; Liu L; Wang Y; Li L; Qin Y; Zhou Q Neoplasma; 2006; 53(6):530-7. PubMed ID: 17167724 [TBL] [Abstract][Full Text] [Related]
15. Effects of all-trans retinoic acid and epidermal growth factor on the expression of nm23-H1 in human hepatocarcinoma cells. Liu F; Qi HL; Chen HL J Cancer Res Clin Oncol; 2000 Feb; 126(2):85-90. PubMed ID: 10664247 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture. Miyazaki H; Fukuda M; Ishijima Y; Takagi Y; Iimura T; Negishi A; Hirayama R; Ishikawa N; Amagasa T; Kimura N Clin Cancer Res; 1999 Dec; 5(12):4301-7. PubMed ID: 10632374 [TBL] [Abstract][Full Text] [Related]
17. Read-through transcript from NM23-H1 into the neighboring NM23-H2 gene encodes a novel protein, NM23-LV. Valentijn LJ; Koster J; Versteeg R Genomics; 2006 Apr; 87(4):483-9. PubMed ID: 16442775 [TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of the promoter for the human metastasis suppressor gene nm23-H1. de la Rosa A; Mikhak B; Steeg PS Arch Med Res; 1996; 27(3):395-401. PubMed ID: 8854401 [TBL] [Abstract][Full Text] [Related]
19. The role of nm23-H1 in the progression of transitional cell bladder cancer. Chow NH; Liu HS; Chan SH Clin Cancer Res; 2000 Sep; 6(9):3595-9. PubMed ID: 10999750 [TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of the promoter region of human nm23-H1, a metastasis suppressor gene. Chen HC; Wang L; Banerjee S Oncogene; 1994 Oct; 9(10):2905-12. PubMed ID: 8084595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]